Analyst Ratings For GlaxoSmithKline plc (LON:GSK)
Today, Goldman Sachs Group, Inc. (The) reiterated its Buy rating on GlaxoSmithKline plc (LON:GSK) with a price target of GBX 1,900.
There are 4 sell ratings, 11 hold ratings, 8 buy ratings on the stock.
The current consensus rating on GlaxoSmithKline plc (LON:GSK) is Hold (Score: 2.17) with a consensus target price of GBX 1,738.82 per share, a potential .
Some recent analyst ratings include
- 7/20/2017-Goldman Sachs Group, Inc. (The) Reiterated Rating of Buy.
- 7/19/2017-Deutsche Bank AG Reiterated Rating of Hold.
- 7/18/2017-Morgan Stanley Reiterated Rating of Equal weight.
- 7/14/2017-Shore Capital Reiterated Rating of Hold.
- 7/13/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.
- 7/13/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 7/5/2017-Citigroup Inc. was Downgraded by analysts at Citigroup Inc. from a “Buy ” rating to a ” Neutral” rating. They now have a GBX 1,700 price target on the stock.
Recent Trading Activity for GlaxoSmithKline plc (LON:GSK)
Shares of GlaxoSmithKline plc closed the previous trading session at 1,625.00 up +23.93 1.49% with 5,755,230 shares trading hands.
